colon_lev: A dataset from a landmark colon cancer trial

Description Usage Format References

Description

A landmark colon cancer trial on the efficacy of levamisole and fluorouracil was reported by Moertel et al. (1990). The trial recruited 929 patients with stage C disease and randomly assigned them to levamisole treatment alone, levamisole combined with fluorouracil, and the control. The dataset here is restricted to the comparison between the combined treatment and control groups, consisting of 304 and 314 patients, respectively.

Usage

1

Format

A data frame with 915 rows and 6 variables:

id

Unique patient ID.

time

Event time (years).

status

Event type; 1 = cancer relapse, 2 = death.

rx

"Lev+5FU" = combined treatment, "Control" = control.

age

Patient age (years) at randomization.

sex

0 = female, 1 = male.

References

MOERTEL, C. G., FLEMING, T. R., MACDONALD, J. S., HALLER, D. G., LAURIE, J. A., GOODMAN, P. J., UNGERLEIDER, J. S., EMERSON, W. A., TORMEY, D. C., GLICK, J. H. et al. (1990). Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl. J. Med. 322, 352–358.


rmt documentation built on May 25, 2021, 9:06 a.m.